Healio53m
Study links beta blocker use to mortality after stem cell transplantation
Taking prescribed beta blockers during hematopoietic stem cell transplantation may increase mortality risk due to suppression of signals from nerves that promote bone marrow regeneration, according to ...
Fintel on MSN8h
UBS Initiates Coverage of Jasper Therapeutics (JSPR) with Buy Recommendation
Fintel reports that on February 13, 2025, UBS initiated coverage of Jasper Therapeutics (NasdaqCM:JSPR) with a Buy ...
The Secret to Healthy Aging? Scientists Uncover the Power of Selenoproteins
A research team from Osaka University investigates the impact of antioxidant enzymes on specific cell types and their role in ...
Mirage News20h
FDA OKs Pfizer's ADCETRIS Combo for Relapsed Lymphoma
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application ...
Adia Nutrition Inc.: Adia Med Advances Towards AHCA Registration to Expand Insurance Coverage for Stem Cell Therapies
Adia Med, the medical division of Adia Nutrition Inc. (OTC Pink: ADIA), proudly announces its ongoing registration with the State of Florida's ...
Adia Med Advances Towards AHCA Registration to Expand Insurance Coverage for Stem Cell Therapies
Adia Med, the medical division of Adia Nutrition Inc. (OTC Pink: ADIA), proudly announces its ongoing registration with the ...
Le Lézard22h
Ensoma Receives Rare Pediatric Disease and Orphan Drug Designations for EN-374 for Treatment of Chronic Granulomatous Disease
Ensoma, a genomic medicines company advancing the future of medicine through one-time, in vivo treatments capable of precisely and durably engineering the hematopoietic system, today announced the U.S ...